Literature DB >> 2298807

Characterization of two populations of statin and the relationship of their syntheses to the state of cell proliferation.

G Ching1, E Wang.   

Abstract

Statin has previously been identified to be a 57-kD protein present in the nuclei of quiescent and senescent human fibroblasts, but not in their replicating counterparts (Wang, E. 1985. J. Cell Biol. 100: 545-551). In the present report we demonstrate by immunoprecipitation analysis of fractionated cellular extracts the existence of two populations of statin. The Triton X-100-soluble statin is found in replicating sparse cultures as well as in quiescent confluent cultures and quiescent serum-starved cultures of young human fibroblasts, but the Triton X-100-insoluble, nuclear envelope-localized statin is present only in the quiescent cultures. Two-dimensional gel analysis of the immunoprecipitated cellular fractions reveals that both populations of statin have an isoelectric point of 5.3. Pulse-chase experiments show that statin is synthesized as a 57-kD polypeptide and is not processed from a precursor of different molecular mass. Experiments on serum stimulation of quiescent cells show that synthesis of the Triton X-100-insoluble statin decreases rapidly during the transition from the G0 to S phase, and that this decrease is accompanied by a slower reduction in synthesis of the Triton X-100-soluble statin. These results suggest that the cellular expression of the two populations of statin may be associated with the mechanisms controlling the transition between the growing state and the quiescent state and confirm the previous finding that the Triton X-100-insoluble, nuclear envelope-localized statin could be used as a marker for cells arrested at the G0 phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298807      PMCID: PMC2116018          DOI: 10.1083/jcb.110.2.255

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  25 in total

1.  Autoantibody to a nuclear antigen in proliferating cells.

Authors:  K Miyachi; M J Fritzler; E M Tan
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

2.  Insulin and epidermal growth factor. Human fibroblast receptors related to deoxyribonucleic acid synthesis and amino acid uptake.

Authors:  M D Hollenberg; P Cuatrecasas
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Phosphorylation of the nuclear lamins during interphase and mitosis.

Authors:  Y Ottaviano; L Gerace
Journal:  J Biol Chem       Date:  1985-01-10       Impact factor: 5.157

6.  Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation.

Authors:  R Bravo; S J Fey; J Bellatin; P M Larsen; J Arevalo; J E Celis
Journal:  Exp Cell Res       Date:  1981-12       Impact factor: 3.905

7.  Identity of the proliferating cell nuclear antigen and cyclin.

Authors:  M B Mathews; R M Bernstein; B R Franza; J I Garrels
Journal:  Nature       Date:  1984 May 24-30       Impact factor: 49.962

8.  Increased organization of cytoskeleton accompanying the aging of human fibroblasts in vitro.

Authors:  E Wang; D Gundersen
Journal:  Exp Cell Res       Date:  1984-09       Impact factor: 3.905

9.  A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells.

Authors:  R Bravo; J E Celis
Journal:  J Cell Biol       Date:  1980-03       Impact factor: 10.539

10.  Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera.

Authors:  Y Takasaki; D Fishwild; E M Tan
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.